SCHEMBL14973111

SCHEMBL14973111

CCOC(=O)c1cnn(C)c1COc1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
POLB P06746 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CSNK1D P48730 1/20 0.44
ALDH1A2 O94788 1/20 0.44
ALDH1A3 P47895 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.44
MAPT P10636 4/20 0.43
KDM4E B2RXH2 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973085 0.89 ALDH1A1 (0.43) PAX8SMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL14973272 0.88 ALDH1A1 (0.49) SMN1; SMN2TDP1ALDH1A1CSNK1DMRGPRX4
SCHEMBL14973180 0.87 BRAF (0.47) PAX8SMN1; SMN2MAPTKDM4ECYP1A2
SCHEMBL14972958 0.86 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1ALDH1A2ALDH1A3MRGPRX4
SCHEMBL14973188 0.86 TSHR (0.52) SMN1; SMN2POLBALDH1A1MAPTKDM4E
SCHEMBL14973299 0.85 JMJD6 (0.45) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL14973126 0.80 MAPT (0.57) SMN1; SMN2POLBALDH1A1MAPTKDM4E
SCHEMBL14973136 0.80 ALDH1A1 (0.45) SMN1; SMN2POLBALDH1A1MAPTKDM4E
SCHEMBL14973274 0.79 SMN1; SMN2 (0.52) SMN1; SMN2POLBALDH1A1MAPTKDM4E
SCHEMBL14972952 0.79 MAPT (0.52) SMN1; SMN2POLBALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A PAX8 4514/4885SMN1; SMN2 3612/4885POLB 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.